ArticleInternational journal of clinical oncology2024

A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.

Hiroshi Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.